dMed Biopharmaceutical funding history / development milestones

C+轮,5000万美元

2021.07.07, 启峰资本

B轮,5000万美元

天使轮,5500万人民币

Note: collected from public online reports, for reference only.

People who follow dMed Biopharmaceutical also follow

dMed Biopharmaceutical Competitors (Similar Companies)

“Professional services for the entire clinical trial process of drug pr”
“Promoting human health”
制药/药业 医药 医药中间体 仿制药
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A high-tech enterprise integrating pharmaceutical production, R&D, and”
“Adhering to the corporate culture of science and excellence, committed”
“A renowned enterprise in China's liver disease and anti-tumor fields”
制药/药业 药物研发 生物制药 医药
医药 新药研发 CRO 生物制剂
CRO 临床医学 医学研究 医药
医药 医药服务 CRO 临床研究
生物科技/生物工程 诊断试剂 原料药 试剂
“A pharmaceutical group committed to the research, development, product”
“Adhering to the pursuit of high quality”
“Technological innovation and commercial application of pharmaceutical ”